Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 205 of the 222 references it cites were found in a registry or an index; 39 of the 219 sources its claims cite were checked for support.
Abstract
OBJECTIVE: This clinical practice guideline addresses the diagnosis and treatment of primary adrenal insufficiency. PARTICIPANTS: The Task Force included a chair, selected by The Clinical Guidelines Subcommittee of the Endocrine Society, eight additional clinicians experienced with the disease, a methodologist, and a medical writer. The co-sponsoring associations (European Society of Endocrinology and the American Association for Clinical Chemistry) had participating members. The Task Force received no corporate funding or remuneration in connection with this review. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to determine the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: The evidence used to formulate recommendations was derived from two commissioned systematic reviews as well as other published systematic reviews and studies identified by the Task Force. The guideline was reviewed and approved sequentially by the Endocrine Society's Clinical Guidelines Subcommittee and Clinical Affairs Core Committee, members responding to a web posting, and the Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments. CONCLUSIONS: We recommend diagnostic tests for the exclusion of primary adrenal insufficiency in all patients with indicative clinical symptoms or signs. In particular, we suggest a low diagnostic (and therapeutic) threshold in acutely ill patients, as well as in patients with predisposing factors. This is also recommended for pregnant women with unexplained persistent nausea, fatigue, and hypotension. We recommend a short corticotropin test (250 μg) as the "gold standard" diagnostic tool to establish the diagnosis. If a short corticotropin test is not possible in the first instance, we recommend an initial screening procedure comprising the measurement of morning plasma ACTH and cortisol levels. Diagnosis of the underlying cause should include a validated assay of autoantibodies against 21-hydroxylase. In autoantibody-negative individuals, other causes should be sought. We recommend once-daily fludrocortisone (median, 0.1 mg) and hydrocortisone (15-25 mg/d) or cortisone acetate replacement (20-35 mg/d) applied in two to three daily doses in adults. In children, hydrocortisone (∼8 mg/m(2)/d) is recommended. Patients should be educated about stress dosing and equipped with a steroid card and glucocorticoid preparation for parenteral emergency administration. Follow-up should aim at monitoring appropriate dosing of corticosteroids and associated autoimmune diseases, particularly autoimmune thyroid disease.
Overview
CoChat Summary
TL;DR
This Endocrine Society clinical practice guideline provides evidence-based recommendations for diagnosing and treating primary adrenal insufficiency (PAI), emphasizing a low diagnostic threshold, the 250-µg short corticotropin test as the diagnostic gold standard, and glucocorticoid/mineralocorticoid replacement with adrenal crisis prevention. It also highlights major evidence gaps, including sparse randomized trial data for replacement regimens and limited diagnostic accuracy studies specifically in PAI.
Key findings
- For diagnosis, the guideline recommends testing patients with indicative symptoms/signs and using the standard-dose 250-µg corticotropin stimulation test as the “gold standard”; peak cortisol below 500 nmol/L (18 µg/dL) at 30 or 60 minutes indicates adrenal insufficiency. The high-dose ACTH stimulation test had a sensitivity of 92% (95% CI, 81–97%) for PAI based on five studies; no studies were available for the low-dose test in PAI. If corticotropin testing is not feasible, a morning cortisol <140 nmol/L (5 µg/dL) plus ACTH is suggested as a preliminary test.
- Autoimmune adrenalitis is the most common cause of PAI, accounting for up to 90% in Western countries; 21-hydroxylase autoantibodies should be measured, and about 30% of CYP21A2 autoantibody-positive individuals progressed to overt PAI during 5-year follow-up. In autoantibody-negative individuals, other causes should be sought, including adrenoleukodystrophy in males via very-long-chain fatty acids and adrenal CT for infiltrative or malignant disease.
- In adults, recommended replacement is hydrocortisone 15–25 mg/d or cortisone acetate 20–35 mg/d in two or three divided doses, with fludrocortisone starting at 50–100 µg/d (median, 0.1 mg) for confirmed aldosterone deficiency. Prednisolone 3–5 mg/d is an alternative, while dexamethasone is suggested against. DHEA replacement may be tried for 6 months in women with low libido, depressive symptoms, and/or low energy despite optimized replacement.
- For adrenal crisis, immediate parenteral hydrocortisone 100 mg (50 mg/m² for children) is recommended, followed by 200 mg/24 h (50–100 mg/m²/d for children), plus fluid resuscitation. Reported adrenal crisis frequencies were 6.6 crises/100 patient-years in a retrospective analysis of 444 patients and 8.3 crises/100 patient-years in a prospective study of 768 patient-years, with a crisis mortality rate of 0.5/100 patient-years.
Methods
- This is a GRADE-based clinical practice guideline developed by an Endocrine Society Task Force with a methodologist and medical writer; recommendations are graded strong (“we recommend,” 1) or weak (“we suggest,” 2), with evidence quality from QEEE (very low) to QQQQ (high), plus ungraded best practice statements.
- Evidence came from two commissioned systematic reviews and other published systematic reviews/studies. The first review compared high-dose vs low-dose ACTH stimulation for diagnosis and found only five studies for high-dose ACTH in PAI and none for low-dose ACTH in PAI. The second review compared glucocorticoid replacement regimens and identified 15 observational studies; mortality, bone density, and adrenal crisis data were very sparse or unavailable, and there was no statistically significant HRQoL difference between hydrocortisone dosages ≥30 mg/d vs <30 mg/d.
- The guideline was reviewed and approved sequentially by Endocrine Society committees, members responding to a web posting, and the Endocrine Society Council; the Task Force received no corporate funding or remuneration.
Limitations
- The paper states that the evidence base is limited: there are no randomized controlled trials for many treatment questions, diagnostic accuracy data for high-dose ACTH in PAI come from only five studies with none for low-dose ACTH in PAI, and the second systematic review found sparse or unavailable data on mortality, bone density, and adrenal crisis, with very low-quality evidence for extended-release/dual-release glucocorticoids. Many recommendations are weak or ungraded best practice statements.
- The paper states that cortisol cutoff values after corticotropin stimulation vary by assay, ACTH assays have analytical bias, and actual clinical cutpoints should be based on assay-specific normative data.
- Evident from the text: the guideline focuses only on PAI and explicitly excludes secondary adrenal insufficiency and critical illness-related corticosteroid insufficiency; some recommendations rely on clinical experience, unsystematic observations, and values/preferences rather than direct systematic evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Algorithm for the diagnostic approach to the patient with PAI. The most common causes of PAI are autoimmune destruction of the adrenal cortex in adults and CAH in children. These etiologies can be screened for using 21-hydroxylase antibodies and a baseline serum 17hydroxyprogesterone level. Males with negative 21-hydroxylase antibodies should be tested for adrenoleukodystrophy with plasma VLCFAs. If these diagnoses are excluded, a CT scan of the adrenals may reveal evidence of adrenal infiltrative processes or metastases. The individual's clinical picture and family history may render some steps in the algorithm redundant or suggest specific genetic syndromes. The latter includes subtypes of autoimmune polyglandular syndromes or specific rare genetic disorders where adrenal failure is part of a broader phenotype. A list of differential diagnoses is provided in Table 2. AHC, adrenal hypoplasia congenita; AI, adrenal insufficiency; VLCFA, very long chain fatty acid. a 17-OHprogesterone > 1000 ng/dL is diagnostic for 21-OH deficiency (14). b VLCFA should be measured in the initial evaluation of preadolescent boys. [Adapted from E. S. Husebye, et al: Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med . 2014;275:104-115 (181), with permission. © John Wiley & Sons, Inc.]](https://figures.cochat.ai/paper-figures/3d28d00e3ab049b5b513e655fd2f1f7a/diagnosis-and-treatment-of-primary-adrenal-insufficiency-an-endocrine-society-figure-1.png)
Verification
Claims the paper makes
35 Valid · 2 Not valid · 109 Not checked · 48 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“However, in all these reports, adrenal crisis was a significant cause of death.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Disputedcites [149] 149. Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G. Premature mortality in patients with Addison's disease: a pop- ulation-based study. J Clin Endocrinol Metab. 2006;91:4849 - 4853. sourceExperimental — accuracy not yet measured
The Mortality section reports 36 deaths attributed to adrenal insufficiency but explicitly says that no patient was reported to have died from adrenal crisis under ICD-10. It also cautions that ICD-9 cannot distinguish adrenal crisis from primary adrenal insufficiency, so the study does not establish crisis as a significant cause of death. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [150] 150. Bensing S, Brandt L, Tabaroj F, et al. Increased death risk and altered cancer incidence pattern in patients with isolated or com- bined autoimmune primary adrenocortical insufficiency. Clin En- docrinol (Oxf). 2008;69:697-704. source
- Not checked — no full text of the sourcecites [7] 7. Erichsen MM, Løvås K, Fougner KJ, et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of prema- ture death. Eur J Endocrinol. 2009;160:233-237. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition to a paired sample of cortisol and ACTH, the adrenal reserve is appropriately and safely assessed in pregnancy by corticotropin stimulation, if indicated (40,41).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Supportedcites [40] 40. Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol (Oxf). 2013;78:497-502. source
The Investigations section (p. 3) calls the short Synacthen test a valid measure of adrenal cortisol reserve, including in pregnancy, and says there is no medical reason to avoid a single diagnostic dose in a pregnant woman. The Summary (p. 1) recommends the test when clinically feasible, alongside paired cortisol and ACTH measurements. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [41] 41. Suri D, Moran J, Hibbard JU, Kasza K, Weiss RE. Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test. J Clin Endocrinol Metab. 2006;91:3866 -3872. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Patients with diseases such as nephrotic syndrome (43) and liver disease (50) as well as those who are in the immediate postoperative period (51) or who require intensive care (52) may have lower CBG and albumin and hence, lower cortisol measurements.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Not checked — no full text of the sourcecites [43] 43. Klose M, Lange M, Rasmussen AK, et al. Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocri- nol Metab. 2007;92:1326 -1333. source
- Not checked — no full text of the sourcecites [50] 50. Vincent RP, Etogo-Asse FE, Dew T, Bernal W, Alaghband-Zadeh J, le Roux CW. Serum total cortisol and free cortisol index give different information regarding the hypothalamus-pituitary-adre- nal axis reserve in patients with liver impairment. Ann Clin Biochem. 2009;46:505-507. source
- Supportedcites [51] 51. le Roux CW, Chapman GA, Kong WM, Dhillo WS, Jones J, Alagh- band-Zadeh J. Free cortisol index is better than serum total cortisol in determining hypothalamic-pituitary-adrenal status in patients undergoing surgery. J Clin Endocrinol Metab. 2003;88:2045- 2048. source
For the part attributed to this source—the immediate postoperative period—the Results report that albumin and CBG fell after surgery, and that seven patients had unexpectedly low postoperative total cortisol. The Discussion attributes those low cortisol values to the fall in CBG. The other conditions in the citing sentence have separate citations. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [52] 52. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350: 1629 -1638. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Interpretation of the diagnostic results requires thorough consideration of pregnancy-associated physiological changes of adrenocortical function (42).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Supportedcites [42] 42. Jung C, Ho JT, Torpy DJ, et al. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. J Clin Endocrinol Metab. 2011;96:1533-1540. source
The Discussion (page not specified in the supplied passage) says that physiological hypercortisolism can be difficult to distinguish from Cushing’s syndrome during pregnancy and emphasizes trimester-specific reference ranges. This supports considering pregnancy-related adrenocortical changes when interpreting diagnostic results. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“An elevated ACTH concentration in the presence of a cortisol in the normal range can be the first sign of early-stage PAI (68).”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
What the sources say
- Could not verifycites [68] 68. Baker PR, Baschal EE, Fain PR, et al. Haplotype analysis discrim- inates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison's disease. J Clin Endo- crinol Metab. 2010;95:E263-E270. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says that 21-hydroxylase autoantibodies usually precede overt Addison’s disease and proposes subsequent adrenal-function testing. Neither that passage nor the passages retrieved by searching for ACTH, cortisol, and early adrenal insufficiency addresses whether elevated ACTH with normal-range cortisol can be an early sign of PAI. (LLM, conf=0.73)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
118 more claims · 24 with their cited sources checked
Create a free account to see all 194 claims and every source verdict.
- Probably not a substantial claim. 22
- It may state two separate claims as one. 58
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In children, glucocorticoid replacement therapy (GCCrt) should be started with hydrocortisone (HC) at a total daily dose of 10 mg/m2, with dose titration according to individual needs (35).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [35]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“no drug suitably mimics the diurnal pattern of cortisol”
From Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells (2018) · cites this paper as Bornstein et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In such cases, a GC dosage increase of 20% to 40% from the 24th week onward is often beneficial (215).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [215]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Nevertheless, no consensus exists regarding the optimal dose and hydrocortisone delivery mode during major stress, and current recommendations are empirical rather than evidence-based (7, 17).”
From Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery (2020) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In primary and secondary adrenal insufficiency, peak cortisol levels < 500 nmol/L (< 18.1 μg/dL), depending on assay, are indicative of adrenal insufficiency (38, 39).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [38]
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > 2.2
“We suggest the low-dose (1 g) corticotropin test for diagnosis of PAI only when the substance itself is in short supply.”
§ Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline > Evidence
“Thus, for practical reasons, the low-dose test may be applicable to situations when corticotropin is in short supply or for other structural or economic reasons.”
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“The Task Force followed the approach recommended by the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group, an international group with expertise in development of evidence-based guidelines (15).”
MethodSapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Enhanced glucocorticoid secretion in critical illness is considered necessary to prevent defense mechanisms (eg, cytokine release) from overshooting with concomitant detrimental toxicity (142, 143).”
BackgroundSapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458 · cited 1×
“In newborns and children, mineralocorticoid sensitivity is lower, thereby usually requiring higher fludrocortisone doses compared to adults (106).”
BackgroundSpeiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468 · cited 4×
“a 17-OHprogesterone 1000 ng/dL is diagnostic for 21-OH deficiency (14).”
BackgroundMethodInfluentialSelf-citationORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349 · cited 1×
“Serum DHEAS concentrations physiologically peak between ages 20 and 30 years, followed by a gradual decline that is independent of menopause (113).”
BackgroundSpeiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Self-citationCorticosteroid insufficiency in acutely ill patients
Cooper, M. S., & Stewart, P. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020529 · Cited by 1,033
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912 · cited 1×
“Although similar arguments for the utility of the low-dose test have been proposed for other special diagnostic challenges such as the detection of adrenal insufficiency in critically ill patients (critical illness-related corticosteroid insufficiency), more evidence is needed to support such a formal recommendation (…”
BackgroundSelf-citationPharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886 · cited 1×
“Because of the short plasma half-life of hydrocortisone (approximately 90 min) (90), multiple dosing is recommended to mimic physiological conditions.”
Background
Research works printed but not linked: 3
- [29]29. Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insuffi- ciency. Ann Intern Med. 2003;139:194 -204.
- [110]110. Keilholz U, Guthrie GP Jr. Adverse effect of phenytoin on miner- alocorticoid replacement with fludrocortisone in adrenal insuffi- ciency. Am J Med Sci. 1986;291:280 -283.
- [177]177. Gan EH, MacArthur K, Mitchell AL, et al. Residual adrenal func- tion in autoimmune Addison's disease: improvement after tetra- cosactide (ACTH1-24) treatment. J Clin Endocrinol Metab. 2014; 99:111-118.
Cited by
Items 801–900 of 1,752
Vidmar, A. P., Kaiser, L., Martin, M. J., Abel, S. A., Kim, A. G., Weitzner, M., Muñoz, C. E., Fisher, L. K., Kim, M. S., & Samakar, K. (2025) · Journal of Medical Case Reports · doi:10.1186/s13256-025-05047-y · Cited by 4
Wasmuth, A., van de Loo, I., Domberg, J., & Harbeck, B. (2025) · Endocrine · doi:10.1007/s12020-025-04192-0 · Cited by 4
Pathophysiology and evaluation of bone health in adrenal diseases
Uygur, M. M., di Filippo, L., Frara, S., Menotti, S., & Giustina, A. (2025) · Endocrine · doi:10.1007/s12020-025-04260-5 · Cited by 5
Preventing adrenal crises: home‐administered subcutaneous hydrocortisone is an option
Rushworth, R. L., Bischoff, C., & Torpy, D. J. (2017) · Internal Medicine Journal · doi:10.1111/imj.13347 · Cited by 5
Self-citationDiagnostik und Therapie der Nebenniereninsuffizienz
Harbeck, B., & Lehnert, H. (2018) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0721-2332 · Cited by 3
Immune Checkpoint Inhibitor–Associated Central Adrenal Insufficiency
Mishra, T., He, G., Sreeram, K., et al. (2018) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000832 · Cited by 4
Adrenal Pathologies During Pregnancy and Postpartum
St‐Jean, M., Bourdeau, I., & Lacroix, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00025-8 · Cited by 5
Autoimmune Polyglandular Syndromes
Sperling, M. A., Angelousi, A. G., & Yau, M. (2021) · MDText.com, Inc. eBooks · Cited by 17
Variations in Morning Serum Cortisol Levels Based on Sex and Pubertal Status
Jacob, S. A., Williams, D. D., Boyd, J., Dileepan, K., & Tsai, S. L. (2019) · Hormone Research in Paediatrics · doi:10.1159/000504539 · Cited by 5
Coronary Spastic Angina Induced by Adrenal Insufficiency
Otsuka, Y., Harada, K., Yasuda, M., Nakano, Y., Hasegawa, K., & Otsuka, F. (2020) · Internal Medicine · doi:10.2169/internalmedicine.4337-19 · Cited by 4
“HL: hyperlipidemia, HT: hypertension, IgE: immunoglobulin E, MI: myocardial infarction ciency (1).”
BackgroundMüller, M., Beiglböck, H., Fellinger, P., Winhofer, Y., Luger, A., Gschwandtner, M. E., Willfort‐Ehringer, A., Koppensteiner, R., Kautzky‐Willer, A., Krebs, M., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01309-2 · Cited by 4
Autoimmune Polyglandular Syndrome Type 2 and Pregnancy
Yanachkova, V. E., Chaveeva, P., Staynova, R. A., et al. (2020) · Folia Medica · doi:10.3897/folmed.62.e48580 · Cited by 4
How to interpret a single cortisol measurement
Shaunak, M., Blair, J., & Davies, J. H. (2020) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2019-318431 · Cited by 4
Cardiovascular outcome in patients with adrenal insufficiency—a therapeutic dilemma
Rahvar, A., Riesel, M., Graf, T., & Harbeck, B. (2021) · Endocrine · doi:10.1007/s12020-020-02571-3 · Cited by 4
Onset of Addison Disease appeared during the first trimester of a twin pregnancy: A case report
Tagetti, A., Marcon, D., Moghetti, P., Spiazzi, G., Fava, C., & Minuz, P. (2021) · Clinical Case Reports · doi:10.1002/ccr3.3784 · Cited by 6
A Rare Case of Addison’s Disease Presenting With Intermittent Pancytopenia and Cardiac Tamponade
Wang, H., Feghali, K., Jetty, V., Astsaturov, A., Evanchuk, D. M., Lam, U. T., & Sweeney, A. T. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2021.05.005 · Cited by 5
Management of panhypopituitarism during pregnancy: A case report
van Zundert, S. K. M., Król, C., & Spaan, J. J. (2021) · Case Reports in Women s Health · doi:10.1016/j.crwh.2021.e00351 · Cited by 4
Sella, A. C., & Halper, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-52215-5_49 · Cited by 4
Cardiac tamponade as a presentation of primary adrenal insufficiency
Page, J. W., Drinkwater, J., Furniss, G., & Sahebjalal, M. (2022) · BMJ Case Reports · doi:10.1136/bcr-2021-248099 · Cited by 5
Zhang, J., Chen, Q., Guo, S., Li, Y., Ma, H., Zheng, R., & Du, M. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0762 · Cited by 4
System-on-Board Integrated Flexible OEGFET Aptasensor for Saliva Testing of Cortisol
Massey, R. S., Gamero, B., & Prakash, R. (2022) · IEEE International Conference on Flexible and Printable Sensors and Systems (FLEPS) · doi:10.1109/fleps53764.2022.9781588 · Cited by 4
Le, B. T., Duong, M. C., Nguyen, T. Q., & Nguyen, C. M. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-250238 · Cited by 6
System-on-Board Integrated Flexible OEGFET Aptasensor for Multianalyte Testing in Saliva
Massey, R. S., & Prakash, R. (2023) · IEEE Journal on Flexible Electronics · doi:10.1109/jflex.2023.3237182 · Cited by 4
“3237182 performed via blood-based enzyme-linked immunosorbent assay (ELISA) [1].”
MethodInfluentialHarbeck, B., Kropp, P. A., & Kreitschmann‐Andermahr, I. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1153595 · Cited by 5
Challenges in establishing animal models for studying osteoimmunology of hypoparathyroidism
Butylina, M., Föger‐Samwald, U., Gelles, K., Pietschmann, P., & Sipos, W. (2023) · Frontiers in Veterinary Science · doi:10.3389/fvets.2023.1163903 · Cited by 6
“These diagnostic criteria are often met before an age of 20 years (31).”
BackgroundWäscher, H., Knauerhase, A., Klar, B., Postrach, T., Weber, M., & Willenberg, H. S. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2180-7108 · Cited by 5
Diagnosing and treating the elderly individual with hypopituitarism
Corsello, A., Paragliola, R. M., & Salvatori, R. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09870-w · Cited by 5
“To reduce the risk of sleep disorders as well as metabolic side-effects that are more frequent in elderly, the last dose should be administered no less than 6 h before bedtime [78].”
Endokrine Nebenwirkungen von Tumortherapien
Braegelmann, J., Führer, D., & Tan, S. (2024) · Die Innere Medizin · doi:10.1007/s00108-024-01731-1 · Cited by 5
Rams, A., Żółciński, M., Zastrzeżyńska, W., et al. (2018) · Journal of Asthma · doi:10.1080/02770903.2017.1414239 · Cited by 4
A Large PROP1 Gene Deletion in a Turkish Pedigree
Görar, S., Türkkahraman, D., & Yararbaş, K. (2018) · Case Reports in Endocrinology · doi:10.1155/2018/2403430 · Cited by 4
Adrenal Crisis and Autoimmune Polyglandular Syndromes
Freeland, Z. K., Lueking, R. R., Tsai-Nguyen, G., Pan, T., & Mora, A. (2017) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2017.11930214 · Cited by 4
Libianto, R., Yang, J., & Fuller, P. J. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-09-20-5619 · Cited by 4
Introduction to Endocrine Disorders in Pregnancy
Pearce, E. N. (2022) · Springer eBooks · doi:10.1007/978-3-030-84367-0_33 · Cited by 4
Shagjaa, T., Sanga, V., & Rossi, G. P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11185379 · Cited by 4
“The Endocrine Society has devoted comprehensive practical guidelines for the management of AI [2].”
BackgroundLewandowski, K. C., Malicka, K., Dąbrowska, K., & Lewiñski, A. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0052 · Cited by 4
Babaya, N., Okuda, Y., Noso, S., Hiromine, Y., Taketomo, Y., Niwano, F., Ueda, K., Tanaka, Y., Yamazaki, Y., Sasano, H., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa184 · Cited by 5
“However, the clinical practice guideline of the Endocrine Society recommends mineral corticoid replacement with fludrocortisone and no restriction on salt intake [13].”
Background10.1016/b978-0-323-64295-8.00032-1
(2000) · Time to knit · doi:10.1016/b978-0-323-64295-8.00032-1 · Cited by 4
Dorin, R. I., Urban, F. K., & Qualls, C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa709 · Cited by 4
Danter, W. R. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.18.549304 · Cited by 4
“The Other important system markers of gram-negative sepsis (N=6) included Presepsin, PCT (ProCalcitonin), CRP (C-reactive protein), MODS (Multiple organ dysfunction syndrome), Catabolic state, and the Normal GUT-Brain Axis. a. Male Data: Presepsin did not show a significant difference between the groups.”
BackgroundResultInfluentialAcute intermittent porphyria: A case report
Sánchez, J. L. B., Rodríguez, L. J. V., & Quintero, R. (2020) · PubMed · doi:10.7705/biomedica.4767 · Cited by 3
“La hiponatremia es la manifestación paraclínica más común en la porfiria intermitente aguda (4,12).”
Tomasello, L., Coppola, A., Pizzolanti, G., Giordano, C. S. D. S., Arnaldi, G., & Guarnotta, V. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1489254 · Cited by 4
Fischetti, G., Barbone, A., Giovannico, L., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1554009 · Cited by 3
Autoimmune Primary Adrenal Insufficiency: Understanding the Past, Present, and Future
Surani, A., & Carroll, T. B. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.04.008 · Cited by 8
Feyzullova, A., Кirilov, G., Elenkova, A. P., Tanev, D., Kalinov, K., Zacharieva, S., & Robeva, R. N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113951 · Cited by 3
“The mean prednisolone dose of 6.88 mg in the investigated AD patients was above the recommended usual dose of 3 to 5 mg/daily [20], varying from 0 mg in a newly diagnosed patient to 10 mg/daily in patients based on their individual needs, concomitant conditions, and preferences as well as medical…”
InfluentialLopes, A. M., Leite, A. R., Ferreira, P., Meira, I., Menino, J., Lourenço, M., Lagoa, J., Viveiros, B., Barbosa, M. J., Monteiro, S. S., et al. (2025) · Endocrine · doi:10.1007/s12020-025-04354-0 · Cited by 4
Biology and Pathology of Cortisol in Sexual Dysfunctions
Omona, K., & Balamaga, S. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_158 · Cited by 5
Diagnostic algorithm of hyponatremia
Lin, R., Grossmann, M., & Warren, A. M. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102053 · Cited by 6
Pituitary hormone deficiencies in prolactinomas: prevalence, predictors, and functional recovery
Prinzi, A., Fava, G., Bacchi, I., Federica, S., Galvano, A., Arnaldi, G., Frasca, F., Guarnotta, V., & Malandrino, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1705300 · Cited by 4
A practical approach to diagnosis and treatment in children with primary adrenal insufficiency
Capalbo, D., Illiano, S., Vasaturo, S., Lorello, P., Rotondo, F. R., Mase, R. D., Bizzarri, C., & Salerno, M. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf229 · Cited by 5
Smoday, I. M., Vuković, V., Oroz, K., Vraneš, H., Kalogjera, L., Gamulin, O., Vlainić, J., Milavić, M., Sikirić, S., Nikolac, N., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19010191 · Cited by 3
Manosroi, W., Atthakomol, P., Buranapin, S., Waisayanand, N., Phimphilai, M., & Kosachunhanun, N. (2020) · The Journal of Medical Investigation · doi:10.2152/jmi.67.95 · Cited by 4
Adrenal insufficiency updates in children
Alcantara, J. R., & Halper, A. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000591 · Cited by 13
Endocrine and metabolic complications of advanced cancer
Ryan, R., & Casey, R. T. (2021) · doi:10.1093/med/9780198821328.003.0084 · Cited by 3
Diagnosis of Addison's disease Using Artificial Neural Network
Džaferović, S., Melić, D., Mihajlović, M., Smajović, A., Bečić, E., Bećirović, L. S., Pokvić, L. G., & Badnjević, A. (2022) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2022.06.011 · Cited by 3
Central hypothyroidism with myxoedema: a less known but clinically challenging presentation
Kaur, K., Kadian, K., Batra, N., & Sridharan, K. (2022) · BMJ Case Reports · doi:10.1136/bcr-2022-250282 · Cited by 4
Plasma corticosteroid‐binding globulin concentrations are preserved in mild cirrhosis
Lee, J. H., Nenke, M. A., Flabouris, K., et al. (2023) · Liver International · doi:10.1111/liv.15524 · Cited by 3
Self-citationPAI-BEL: a Belgian multicentre survey of primary adrenal insufficiency
Driessens, N., Prasai, M., Alexopoulou, O., Block, C. E. M. D., Caenegem, E. V., T'Sjoen, G. G., Nobels, F. R. E., Ghys, C., Vroonen, L., Jonas, C., et al. (2023) · Endocrine Connections · doi:10.1530/ec-23-0044 · Cited by 5
Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
Ornelas, M., Borges‐Canha, M., Gouveia, P., Ferreira, M., Resende, E., Sá, M., & Abreu, S. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000654 · Cited by 3
“Primary adrenal insufficiency was defined by a morning cortisol level below 5 μg/dL and plasmatic adrenocorticotropic hormone (ACTH) over twice the upper limit of the reference range (6).”
BackgroundA Novel Variant in NR5A1 Presenting as 46,XY Difference of Sex Development
Yu, Y., Lee, P. A., Huerta‐Saenz, L., & Allen, N. G. (2023) · JCEM Case Reports · doi:10.1210/jcemcr/luad103 · Cited by 3
“He was not hypoglycemic or hypercalcemic, denied nausea or vomiting, and did not exhibit signs or symptoms of adrenal crisis [7].”
Khurshid, A., Satti, Z., Jose, R., et al. (2023) · Cureus · doi:10.7759/cureus.45598 · Cited by 3
“Primary adrenal insufficiency (PAI) presents when damage to the adrenal glands causes a deficiency in androgens, cortisol, and aldosterone [5].”
BackgroundYazidi, M., Salem, M. B., Oueslati, I., Khessairi, N., Chaker, F., & Chihaoui, M. (2023) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2023.10.004 · Cited by 5
Basal cortisol levels do not predict adrenal responsiveness in acute decompensated cirrhosis
Wentworth, B. J., Schliep, M. K., Novicoff, W. M., Henry, Z. H., & Siragy, H. M. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002694 · Cited by 3
“However, as noted in societal guidelines, this cutoff value is problematic since it was not derived from an adrenal insufficiency population and is subject to variation in cortisol assay measurements [8].”
BackgroundMethodInfluentialSakalkale, A., Choi, C. C., Krawitz, R., et al. (2024) · Radiology Case Reports · doi:10.1016/j.radcr.2024.03.005 · Cited by 3
“A short synachten (corticotropin) test is considered a “gold standard” diagnostic tool for AI [3 ,18 ,19] .”
BackgroundAdrenal insufficiency as part of X-linked adrenoleukodystrophy
Enikeeva, S., Чугунов, І., Kareva, M., Куркина, М. В., Zakharova, E. Y., Michailova, S. V., Bezlepkina, O. B., Peterkova, V. A., & Mokrysheva, N. G. (2023) · Problems of Endocrinology · doi:10.14341/probl13335 · Cited by 7
Treatment and Prevention of Adrenal Crisis and Family Education
Çamtosun, E., & Sangün, Ö. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-12-s · Cited by 9
Detomas, M., Deutschbein, T., Dolce, P., Möhres, Y., Faßnacht, M., & Altieri, B. (2025) · Pituitary · doi:10.1007/s11102-024-01493-x · Cited by 3
“ACTH deficiency was diagnosed when morning serum cortisol levels (between 08:00–09:00 h) were low ( 5 µg/ dL) and/or cortisol peaked below 18 µg/L after stimulation with synthetic ACTH (250 µg iv) [18].”
Katabami, T., Matsuba, R., Nagasaka, T., Yamamoto, Y., Sakai, K., & Sone, M. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0696 · Cited by 3
Androgen deficiency in women with adrenal insufficiency. Dehydroepiandrosterone. Review
Nuralieva, N. F., Yukina, M. Y., Troshina, E. A., & Platonova, N. M. (2018) · GYNECOLOGY · doi:10.26442/2079-5696_2018.4.35-39 · Cited by 3
Turmel-Roy, J., Bédard, M.-A., Millette, M., Simonyan, D., Proulx‐Gauthier, J., & Rousseau-Nepton, I. (2020) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2020-0219 · Cited by 4
Endokrinologische Notfälle: Diagnostik und Initialtherapie beherrschen
Schilling, T., Räpple, D., Heymer, J., Krohn, A., Schmid, S., & Müller, M. (2020) · Notfall + Rettungsmedizin · doi:10.1007/s10049-020-00766-9 · Cited by 3
Anti-ZnT8 autoantibodies: A new marker to be screened in patients with anti-adrenal antibodies
Bost, C., Teoli, J., Dechomet, M., Fortenfant, F., & Fabien, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.09.019 · Cited by 3
Hypoglycaemia associated with critical illness and hormone deficiencies: a narrative review
Fernandez, C. J., Rajgopal, R. K., & Pappachan, J. M. (2021) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm-2020-ash-01 · Cited by 3
“In healthy nondiabetic subjects with a stable sleep-wake cycles, the serum cortisol levels begin to rise by 04:00 hours, reach a peak between 07:00 and 09:00 hours, and then fall for the rest of the day to reach the nadir (<50% of the morning cortisol levels) between 22:00 and 02:00 hours (85,86).”
BackgroundRelative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
Tripathi, P. R., Sarma, M. S., Yachha, S. K., Aggarwal, A., Bhatia, V., Kumar, A., Srivastava, A., & Poddar, U. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001486 · Cited by 3
Rates of adrenal insufficiency using a monoclonal vs. polyclonal cortisol assay
McNerney, K. P., & Arbeláez, A. M. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0519 · Cited by 4
Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency
Guarnotta, V., Tomasello, L., & Giordano, C. S. D. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-04904-w · Cited by 5
The challenges of managing type 1 diabetes with other autoimmune diseases
Salloum, M., & Poole, R. (2022) · Practical Diabetes · doi:10.1002/pdi.2418 · Cited by 4
Silva, C., Patel, T., & Lam, C. (2022) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0444 · Cited by 3
Auer, M. K., Paizoni, L., Nowotny, H. F., Lottspeich, C., Tschaidse, L., Schmidt, H., Bidlingmaier, M., & Reisch, N. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106271 · Cited by 3
An unusual cause of adrenal insufficiency with elevation of 17-hydroxyprogesterone: case report
Teti, C., Bezante, G., Gatto, F., Khorrami, K., Albertelli, M., Falchi, M., Bovio, G., Nati, S., Ferone, D., & Boschetti, M. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01374-7 · Cited by 4
“However, in patients with confirmed cortisol deficiency accompanied by plasma ACTH two times above the upper limit of normality, as well as typical clinical signs and symptoms of PAI, as in our patient, the baseline evaluation is sufficient for the diagnosis [2].”
BackgroundInfluentialHirata, R., Tago, M., Yamashita, S., Yamamoto, S., Yaita, S., Hirakawa, Y., Ono, M., & Yamashita, S. (2023) · Clinical Case Reports · doi:10.1002/ccr3.7925 · Cited by 3
Spectrum of Adrenal Dysfunction in Hemoglobin E/Beta Thalassemia
Singha, A., Mukhopadhyay, P., & Ghosh, S. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad579 · Cited by 3
Recovery of adrenal function after stopping mitotane in patients with adrenocortical carcinoma
Altieri, B., Kimpel, O., Megerle, F., Detomas, M., Chifu, I. O., Fuß, C. T., Quinkler, M. O., Kroiß, M., & Faßnacht, M. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae007 · Cited by 4
Francisco, A., Yılmaz, A. M., Navarro, C. D. C., Önder, A., Yıldız, M., Demirkol, Y. K., Karademir-Yilmaz, B., menevse, T. S., Güran, T., & Castilho, R. F. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae011 · Cited by 4
Impact of systemic treatments for advanced thyroid cancer on the adrenal cortex
Colombo, C., Ceruti, D., Succi, M., Leo, S. D., Trevisan, M., Moneta, C., & Fugazzola, L. (2022) · European Thyroid Journal · doi:10.1530/etj-23-0246 · Cited by 4
“In patients with documented PAI, but also in patients with persistently increased ACTH levels and fatigue grade 2 or higher, CA replacement treatment was shown to be effective.”
BackgroundMethodInfluentialGoder, N., Gerstenhaber, F., Gal‐Oz, A., Stavi, D., Angel, Y., Nini, A., Lichter, Y., & Sold, O. (2024) · Critical Care Explorations · doi:10.1097/cce.0000000000001086 · Cited by 6
“Second, we used morning serum cortisol levels, rather than Adrenocorticotropic hormone test, as a marker of CIRCI, which in some studies was found inferior in the ability predict outcome or response to corticosteroids treatment in septic shock (39, 43).”
MethodImproving adrenalectomies: Safe outcomes of partial adrenalectomies and suitable characteristics
Hla, D. A., Celik, N. B., & Elli, E. F. (2024) · Surgery Open Science · doi:10.1016/j.sopen.2024.07.001 · Cited by 3
“Thus, the loss of both glands necessitates lifelong steroid replacement therapy, and even unilateral adrenalectomy has been shown to cause insufficiency in up to 27 % of patients [2,3].”
BackgroundEtiology of combined pituitary hormone deficiency: GNAO1 as a novel candidate gene
Plachý, L., Dušátková, P., Maratová, K., Amaratunga, S. A., Zemkova, D., Neuman, V., Koloušková, S., Obermannová, B., Šnajderová, M., Šumník, Z., et al. (2024) · Endocrine Connections · doi:10.1530/ec-24-0217 · Cited by 3
Alekrish, Y., Alotaibi, M., & Ekhzaimy, A. A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09905-w · Cited by 3
“However, oral hydrocortisone does not mimic the normal circadian cortisol rhythm or its pulsatile secretion due to its short half-life [20, 21].”
Piazzola, C., Dreves, B., Albarel, F., Nakache, J., Morera, J., Joubert, M., Brue, T. C., Reznik, Y., & Castinetti, F. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae174 · Cited by 4
“Endocrinologists therefore mainly focus on blood pressure and blood potassium to tailor fludrocortisone [6], with a starting dose of 50 to 100 µg/day and no salt restriction.”
BackgroundOrmoni steroidei surrenalici: deidroepiandrosterone e deidroepiandrosterone-solfato
Dorizzi, R. M., del GdS-EMM, A. N., & BRESCIA, V. (2024) · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine · doi:10.23736/s1825-859x.24.00262-7 · Cited by 3
Kanazawa, K., Hijikata, M., & Kuwabara, K. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.10.009 · Cited by 3
The Use of Prednisolone 2.5 mg Daily During Ramadan Fasting in Patients With Adrenal Insufficiency
Mok, M., Farook, N. S., Hee, N. K. Y., Sarvanandan, T., Lim, Q. H., Lim, L., Vethakkan, S. R., & Ratnasingam, J. (2024) · Clinical Endocrinology · doi:10.1111/cen.15176 · Cited by 3
“Guidelines recommend using the lowest possible doses of glucocorticoid replacement to prevent adverse effects of excess dosing including weight gain, hyperglycaemia, bone loss and other cardio ‐ metabolic complications, while maintaining adequate replacement for day ‐ to ‐ day activities [12].”
Insights in non-CAH pediatric primary adrenal insufficiency: a single-center experience from India
Daga, A., Karlekar, M. P., Lila, A. R., Sarathi, V., Sharma, A., Memon, S. S., Barnabas, R., Patil, V. A., Thakker, H., Shah, N., et al. (2025) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2024-0476 · Cited by 7
Wagoner, J. K., & Choksi, P. U. (2025) · doi:10.1093/med/9780197754153.003.0091 · Cited by 2
Sex and age differences in cortisol levels during glucagon stimulation test in children
Borghammar, C., Svensson, J., Tidblad, A., & Elfving, M. (2025) · BMC Pediatrics · doi:10.1186/s12887-025-05784-5 · Cited by 4
“The glucagon stimulation test (GST) and adrenocorticotropic hormone (ACTH) stimulation test are pharmacological stimulation tests that can be used to assess adrenal cortisol production [2, 3, 4, 5].”
De-evolution of diagnostic testing for adrenal insufficiency
Kline, G. A., & Holmes, D. T. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30145-0 · Cited by 3
Tur, J., Badole, S. L., Cheng, F., et al. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-3079-9 · Cited by 3
Infectious causes of Addison’s disease: 1 organ—2 organisms!
Muhammed, H., Nampoothiri, R. V., Gaspar, B. L., & Jain, S. (2018) · BMJ Case Reports · doi:10.1136/bcr-2017-223633 · Cited by 4
Type 2 Autoimmune Polyglandular Syndrome Presenting with Hyperpigmentation and Amenorrhea
Gaba, N., Gaba, S., Singla, M., & Gupta, M. (2020) · Cureus · doi:10.7759/cureus.7772 · Cited by 6
“The preferred regime for chronic adrenal insufficiency is oral hydrocortisone taken in three divided doses, with around half of the total dose taken in morning to mimic the natural circadian rhythm of cortisol [8].”
BackgroundDifferential diagnosis of hypoglycemia
Schovánek, J., Cibičková, Ľ., Čtvrtlík, F., Fryšák, Z., & Karásek, D. (2020) · Vnitřní lékařství · doi:10.36290/vnl.2020.022 · Cited by 4
Metadata
- Authors
- Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., & Torpy, D. J.
- Affiliations
- King's College London (GB)
- Mayo Clinic (US)
- National Institutes of Health (US)
- Royal Adelaide Hospital (AU)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2016-02
- Volume
- 101
- Issue
- 2
- Pages
- 364-389
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4880116
- OpenAlex
- W2234917292
- Cited by
- 1,769
- References
- 222
- Citations by year
- 2026: 187 · 2025: 198 · 2024: 180 · 2023: 191 · 2022: 180 · 2021: 206 · 2020: 165 · 2019: 149 · 2018: 148 · 2017: 102 · 2016: 54
- FWCI
- 151.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by-nc-nd)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by-nc-nd)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- European Society of Endocrinology
- Novo Nordisk Fonden (NNF14OC0011005)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK062027)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- Addison's disease, diagnosis, hydrocortisone replacement, fludrocortisone, corticosteroid dose, stress dosing, 21-hydroxylase autoantibodies, autoimmune thyroid disease, pregnancy, glucocorticoid therapy, autoimmune adrenal insufficiency
- MeSH terms
- Adrenal Insufficiency, Female, Humans, Pregnancy, Societies, Medical, Evidence-Based Medicine, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.